Mesoblast Common Stock Total Equity from 2010 to 2025
| MESO Stock | USD 17.15 1.61 10.36% |
Common Stock Total Equity | First Reported 2012-12-31 | Previous Quarter 1.1 B | Current Value 1.2 B | Quarterly Volatility 158.5 M |
Check Mesoblast financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mesoblast's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Interest Expense of 24.9 M or Selling General Administrative of 20.5 M, as well as many indicators such as Price To Sales Ratio of 122, Dividend Yield of 0.0 or PTB Ratio of 1.5. Mesoblast financial statements analysis is a perfect complement when working with Mesoblast Valuation or Volatility modules.
Mesoblast | Common Stock Total Equity |
Latest Mesoblast's Common Stock Total Equity Growth Pattern
Below is the plot of the Common Stock Total Equity of Mesoblast over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Mesoblast's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mesoblast's overall financial position and show how it may be relating to other accounts over time.
| Common Stock Total Equity | 10 Years Trend |
|
Common Stock Total Equity |
| Timeline |
Mesoblast Common Stock Total Equity Regression Statistics
| Arithmetic Mean | 922,446,650 | |
| Geometric Mean | 896,865,106 | |
| Coefficient Of Variation | 24.46 | |
| Mean Deviation | 190,464,482 | |
| Median | 910,405,000 | |
| Standard Deviation | 225,663,333 | |
| Sample Variance | 50923.9T | |
| Range | 683.2M | |
| R-Value | 0.89 | |
| Mean Square Error | 11144.9T | |
| R-Squared | 0.80 | |
| Slope | 42,281,653 | |
| Total Sum of Squares | 763859.1T |
Mesoblast Common Stock Total Equity History
About Mesoblast Financial Statements
Mesoblast investors utilize fundamental indicators, such as Common Stock Total Equity, to predict how Mesoblast Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Common Stock Total Equity | 1.3 B | 939.2 M |
Check out the analysis of Mesoblast Correlation against competitors. To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesoblast. If investors know Mesoblast will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesoblast listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.05) | Revenue Per Share | Quarterly Revenue Growth (0.41) | Return On Assets | Return On Equity |
The market value of Mesoblast is measured differently than its book value, which is the value of Mesoblast that is recorded on the company's balance sheet. Investors also form their own opinion of Mesoblast's value that differs from its market value or its book value, called intrinsic value, which is Mesoblast's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesoblast's market value can be influenced by many factors that don't directly affect Mesoblast's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesoblast's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesoblast is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesoblast's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.